RCM Technologies, Inc.NASDAQ: RCMT

RCM Technologies, Inc. Announces Third Quarter 2026 Results

· Issued by RCM Technologies, Inc. via GlobeNewswire

Summary by 6ix AI

RCM Technologies, Inc., which provides engineering, specialty healthcare and information technology services, reported revenue of $73.4 million for the thirteen weeks ended October 3, 2026, up 4.4% from $70.3 million for the thirteen weeks ended September 27, 2025.

Key details

  • Net income under standard accounting rules (GAAP) was $2.7 million, or $0.37 per diluted share, for the thirteen weeks ended October 3, 2026, compared with $2.3 million, or $0.30 per diluted share, a year earlier. Gross profit was $19.9 million, up 2.7% from $19.4 million.
  • Adjusted EBITDA, a company-defined measure of earnings before interest, taxes, depreciation and certain other items, was $6.3 million for the quarter, up 14.2% from $5.5 million. Adjusted net income per diluted share was $0.53, up 26.2% from $0.42.
  • For the thirty-nine weeks ended October 3, 2026, revenue was $250.3 million, up 7.4% from $232.9 million for the thirty-nine weeks ended September 27, 2025, and gross profit was $66.0 million, up 3.7% from $63.7 million.
  • GAAP net income for the thirty-nine weeks ended October 3, 2026 was $11.5 million, or $1.56 per diluted share, compared with $10.2 million, or $1.34 per diluted share, for the prior-year period.
  • Adjusted EBITDA for the thirty-nine weeks ended October 3, 2026 was $23.8 million, up 11.0% from $21.4 million, and adjusted net income per diluted share was $2.01, up 16.2% from $1.73.

6ix AI wrote this summary from the release below and checked it against the release.

PENNSAUKEN, N.J., Nov. 12, 2026 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty healthcare, and information technology services, today announced financial results for the thirteen and thirty-nine weeks ended October 3, 2026.

RCMT reported revenue of $73.4 million for the thirteen weeks ended October 3, 2026 (the current quarter), an increase of 4.4% compared to $70.3 million for the thirteen weeks ended September 27, 2025 (the comparable prior quarter). Gross profit was $19.9 million for the current quarter, a 2.7% increase from $19.4 million for the comparable prior quarter. The Company experienced GAAP net income of $2.7 million, or $0.37 per diluted share, for the current quarter compared to $2.3 million, or $0.30 per diluted share, for the comparable prior quarter. The Company experienced adjusted EBITDA (non-GAAP) of $6.3 million for the current quarter, as compared to $5.5 million for the comparable prior quarter, an increase of 14.2%. The Company experienced $0.53 of adjusted net income per diluted share (non-GAAP) for the current quarter as compared to $0.42 for the comparable prior quarter, an increase of 26.2%.

RCMT reported revenue of $250.3 million for the thirty-nine weeks ended October 3, 2026 (the current period), an increase of 7.4% compared to $232.9 million for the thirty-nine weeks ended September 27, 2025 (the comparable prior-year period). Gross profit was $66.0 million for the current period, a 3.7% increase from $63.7 million for the comparable prior-year period. The Company experienced GAAP net income of $11.5 million, or $1.56 per diluted share, for the current period compared to $10.2 million, or $1.34 per diluted share, for the comparable prior-year period. The Company experienced adjusted EBITDA (non-GAAP) of $23.8 million for the current period, as compared to $21.4 million for the comparable prior-year period, an increase of 11.0%. The Company experienced $2.01 of adjusted net income per diluted share (non-GAAP) for the current period as compared to $1.73 for the comparable prior-year period, an increase of 16.2%.

About RCM
RCM Technologies, Inc. (NasdaqGM: RCMT) is a business and technology solutions provider with world-class talent in key market segments. We help design, build, and enable the Industries of Tomorrow, Today. Operating at the intersection of resources, critical infrastructure and modernization of industries, RCM is a provider of services in Healthcare, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions. www.rcmt.com.

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company’s services, expectations regarding our future revenues and other financial results, such as cash flows, our pipeline, and potential project wins, and our expectations for investment and growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

Tables to Follow

RCM Technologies, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(In Thousands, Except Share and Per Share Amounts)
Thirteen Weeks Ended
October 3,
2026
September 27,
2025
Revenue$73,401$70,289
Cost of services53,47550,879
Gross profit19,92619,410
Selling, general and administrative14,82314,933
Depreciation and amortization of property and equipment565539
Operating income4,5383,938
Other expense, net427614
Income before income taxes4,1113,324
Income tax expense1,3951,065
Net income$2,716$2,259
Diluted net earnings per share data$0.37$0.30
Diluted weighted average shares outstanding7,303,2277,614,695
Thirty-Nine Weeks Ended
October 3,
2026
September 27,
2025
Revenue$250,255$232,928
Cost of services184,225169,263
Gross profit66,03063,665
Selling, general and administrative45,92045,179
Depreciation and amortization of property and equipment1,6771,364
Operating income18,43317,122
Other expense, net1,7262,241
Income before income taxes16,70714,881
Income tax expense5,2464,651
Net income$11,461$10,230
Diluted net earnings per share data$1.56$1.34
Diluted weighted average shares outstanding7,358,8467,656,929

RCM Technologies, Inc.
Supplemental Operating Results on a Non-GAAP Basis
(Unaudited)
(In Thousands, Except Per Share Amounts)

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures (“Adjusted operating income,” “EBITDA,” “Adjusted EBITDA,” “Adjusted net income” and “Adjusted diluted net earnings per share”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons. Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share should not be considered alternatives to operating income or net income, as the case may be, as an indicator of performance. In addition, Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The following unaudited table presents the Company’s GAAP operating income and GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share for the thirteen and thirty-nine weeks ended October 3, 2026, and September 27, 2025.

Thirteen Weeks EndedThirty-Nine Weeks Ended
October 3,
2026
September 27,
2025
October 3,
2026
September 27,
2025
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
GAAP operating income$4,538$3,938$18,433$17,122
Adjustments
Excess professional fees--647-
Equity compensation1,1911,0333,0232,939
Adjusted operating income (non-GAAP)$5,729$4,971$22,103$20,061
GAAP net income$2,716$2,259$11,461$10,230
Income tax expense1,3951,0655,2464,651
Interest expense, net4485841,8191,885
Depreciation of property and equipment5655391,6771,364
EBITDA (non-GAAP)$5,124$4,447$20,203$18,130
Adjustments
Excess professional fees--647-
(Gain) loss on foreign currency transactions(21)30(93)356
Equity compensation1,1911,0333,0232,939
Adjusted EBITDA (non-GAAP)$6,294$5,510$23,780$21,425
RCM Technologies, Inc.
Supplemental Operating Results on a Non-GAAP Basis (Continued)
(Unaudited)
(In Thousands)
Thirteen Weeks EndedThirty-Nine Weeks Ended
October 3,
2026
September 27,
2025
October 3,
2026
September 27,
2025
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
GAAP net income$2,716$2,259$11,461$10,230
Adjustments
Excess professional fees--647-
(Gain) loss on foreign currency transactions(21)30(93)356
Equity compensation1,1911,0333,0232,939
Tax impact from normalized rate(31)(119)(231)(257)
Adjusted net income (non-GAAP)$3,855$3,203$14,807$13,268
GAAP diluted net earnings per share$0.37$0.30$1.56$1.34
Adjustments
Excess professional fees--$0.08-
(Gain) loss on foreign currency transactions($0.00)$0.01($0.01)$0.05
Equity compensation$0.16$0.13$0.41$0.38
Tax impact from normalized rate(a)($0.00)($0.02)($0.03)($0.04)
Adjusted diluted net earnings per share (non-GAAP)$0.53$0.42$2.01$1.73
(a)Amount reflects an adjustment to income tax expense applied to non-GAAP adjusted consolidated taxable income. The Company used an estimated effective income tax rate of 27.0% for both periods presented, approximating the Company’s federal USA income tax rate plus the tax-affected rate for states and Puerto Rico.
RCM Technologies, Inc.
Summary of Selected Income Statement Data
(Unaudited)
(In Thousands)
Thirteen Weeks Ended October 3, 2026
Specialty
Healthcare
EngineeringLife Sciences,
Data and Solutions
Consolidated
Revenue$33,709$30,743$8,949$73,401
Cost of services25,11322,7835,57953,475
Gross profit$8,596$7,960$3,370$19,926
Gross profit margin25.5%25.9%37.7%27.1%
Thirteen Weeks Ended September 27, 2025
Specialty
Healthcare
EngineeringLife Sciences,
Data and Solutions
Consolidated
Revenue$30,000$31,419$8,870$70,289
Cost of services21,01024,5075,36250,879
Gross profit8,9906,9123,50819,410
Gross profit margin30.0%22.0%39.5%27.6%
Thirty-Nine Weeks Ended October 3, 2026
Specialty
Healthcare
EngineeringLife Sciences,
Data and Solutions
Consolidated
Revenue$126,541$96,405$27,309$250,255
Cost of services91,34176,10316,781184,225
Gross profit$35,200$20,302$10,528$66,030
Gross profit margin27.8%21.1%38.6%26.4%
Thirty-Nine Weeks Ended September 27, 2025
Specialty
Healthcare
EngineeringLife Sciences,
Data and Solutions
Consolidated
Revenue$116,105$90,082$26,741$232,928
Cost of services82,63470,49616,133169,263
Gross profit33,47119,58610,60863,665
Gross profit margin28.8%21.7%39.7%27.3%
RCM Technologies, Inc.
Consolidated Balance Sheets
(Unaudited)
(In thousands, except share amounts)
October 3,January 3,
20262026
Current assets:
Cash$1,884$2,922
Accounts receivable and contract assets, net of provision for credit losses of $871 at October 3, 2026 and January 3, 202685,01681,243
Transit accounts receivable6,2728,017
Prepaid expenses and other current assets6,2827,704
Total current assets99,45499,886
Property and equipment, net6,3697,265
Other assets:
Deposits261261
Deferred tax assets, foreign66
Goodwill22,14722,147
Operating right of use assets4,9454,832
Total other assets27,35927,246
Total assets$133,182$134,397
Current liabilities:
Accounts payable and accrued expenses$14,590$9,649
Transit accounts payable8,99316,247
Accrued payroll and related costs13,24610,784
Finance lease payables799843
Income taxes payable50391
Operating lease liabilities1,1941,209
Deferred revenue9,05814,761
Total current liabilities47,93053,884
Deferred income taxes, net, domestic5,6735,673
Finance lease payables, net of current portion-380
Operating lease liabilities, net of current portion3,9413,813
Borrowings under revolving credit facility22,68224,673
Total liabilities80,22688,423
Contingencies (note 16) and Commitments (note 15)
Stockholders’ equity:
Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding--
Common stock, $0.05 par value; 40,000,000 shares authorized; 18,132,420 shares issued and 7,131,213 shares outstanding at October 3, 2026 and 18,004,241 shares issued and 7,351,400 shares outstanding at January 3, 2026906900
Additional paid-in capital124,755122,244
Accumulated other comprehensive loss(3,164)(2,814)
Retained earnings21,85710,396
Treasury stock at cost, 11,001,207 shares at October 3, 2026 and 10,652,841 shares at January 3, 2026(91,398)(84,752)
Stockholders’ equity52,95645,974
Total liabilities and stockholders’ equity$133,182$134,397
RCM Technologies, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(In Thousands)
Thirteen Weeks Ended
October 3
2026
September 27,
2025
Net income$2,716$2,259
Adjustments to reconcile net income to cash used in operating activities1,5811,825
Changes in operating assets and liabilities:
Accounts receivable and contract assets(3,208)515
Prepaid expenses and other current assets(599)(175)
Net of transit accounts receivable and payable(5,124)(7,659)
Accounts payable and accrued expenses2033,312
Accrued payroll and related costs3722,431
Operating lease liabilities(181)(274)
Income taxes payable(301)(538)
Deferred revenue819(2,939)
Deposits-(19)
Total adjustments(6,438)(3,521)
Net cash used in operating activities(3,722)(1,262)
Net cash used in investing activities(276)(498)
Net cash used in financing activities(603)(2,379)
Effect of exchange rate changes on cash(100)(24)
Decrease in cash($4,701)($4,163)
Thirty-Nine Weeks Ended
October 3
2026
September 27,
2025
Net income$11,461$10,230
Adjustments to reconcile net income to cash used in operating activities5,1755,080
Changes in operating assets and liabilities:
Accounts receivable and contract assets(3,488)(5,249)
Prepaid expenses and other current assets1,4202,865
Net of transit accounts receivable and payable(5,509)(9,330)
Accounts payable and accrued expenses5,155(69)
Accrued payroll and related costs2,4802,860
Operating lease liabilities(804)(809)
Income taxes payable(337)(108)
Deferred revenue(5,734)2,098
Deposits(1)(48)
Total adjustments(1,643)(2,710)
Net cash provided by operating activities9,8187,520
Net cash used in investing activities(477)(1,398)
Net cash used in financing activities(9,875)(9,471)
Effect of exchange rate changes on cash(504)(71)
Decrease in cash($1,038)($3,420)
RCM Technologies, Inc.Tel:  856.356.4500Corporate Contacts:
2500 McClellan Avenueinfo@rcmt.comBradley S. Vizi
Pennsauken, NJ 08109www.rcmt.comExecutive Chairman
Kevin D. Miller
Chief Financial Officer

View original source (GlobeNewswire)RCM Technologies, Inc. on 6ix

Story so far

Earlier from RCM Technologies

All RCM Technologies news releases